Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Int J Mol Sci ; 16(8): 17088-100, 2015 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-26225962

RESUMO

S-Methylmethionine sulfonium (SMMS) was reported to have wound-healing effects; we therefore have investigated the photoprotective effect of SMMS in the present study. SMMS increased the viability of keratinocyte progenitor cells (KPCs) and human dermal fibroblasts (hDFs) following ultraviolet B (UVB) irradiation, and reduced the UVB-induced apoptosis in these cells. SMMS increased the phosphorylation of extracellular signal-regulated kinases (ERK), and the inhibitor of the mitogen-activated protein kinase pathway significantly decreased the SMMS-induced viability of KPCs and hDFs. In addition, SMMS attenuated the UVB-induced reactive oxygen species (ROS) generation in KPCs and hDFs. SMMS induced the collagen synthesis and reduced the matrix metalloproteinase-1 expression in UVB-irradiated hDFs. In animal studies, application of 5% and 10% SMMS before and after UVB-irradiation significantly decreased the UVB-induced erythema index and depletion of Langerhans cells. In summary, SMMS protects KPCs and hDFs from UVB irradiation, and reduces UVB-induced skin erythema and immune suppression. Therefore, SMMS can be used as a cosmetic raw material, and protect skin from UVB.


Assuntos
Eritema/tratamento farmacológico , Pele/efeitos dos fármacos , Protetores Solares/farmacologia , Vitamina U/farmacologia , Vitaminas/farmacologia , Animais , Linhagem Celular , Colágeno/genética , Colágeno/metabolismo , Eritema/etiologia , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Fibroblastos/efeitos da radiação , Humanos , Queratinócitos/efeitos dos fármacos , Queratinócitos/metabolismo , Queratinócitos/efeitos da radiação , Metaloproteinase 1 da Matriz/metabolismo , Ratos , Espécies Reativas de Oxigênio/metabolismo , Pele/efeitos da radiação , Protetores Solares/uso terapêutico , Raios Ultravioleta/efeitos adversos , Vitamina U/uso terapêutico , Vitaminas/uso terapêutico
2.
Lik Sprava ; (3-4): 87-94, 2015.
Artigo em Russo | MEDLINE | ID: mdl-26827446

RESUMO

The article summarizes clinical features of the course when chronic pancreatitis goes in combination with diseases of gastroduodenal and hepatobiliary systems and features of functional and morphological changes. The article also represents justification of need to include the combined medicine Doktovit (combination of Dexpanthenol and S-methylmethionine) into complex treatment of the pathology, describes mechanism of its gastro protective and reparative action.


Assuntos
Antioxidantes/uso terapêutico , Duodenopatias/fisiopatologia , Hepatopatias/fisiopatologia , Pancreatite Crônica/fisiopatologia , Substâncias Protetoras/uso terapêutico , Gastropatias/fisiopatologia , Duodenopatias/complicações , Duodenopatias/tratamento farmacológico , Duodenopatias/metabolismo , Heme/análogos & derivados , Heme/uso terapêutico , Humanos , Hepatopatias/complicações , Hepatopatias/tratamento farmacológico , Hepatopatias/metabolismo , Meglumina/análogos & derivados , Meglumina/uso terapêutico , Pancreatite Crônica/complicações , Pancreatite Crônica/tratamento farmacológico , Pancreatite Crônica/metabolismo , Ácido Pantotênico/uso terapêutico , Gastropatias/complicações , Gastropatias/tratamento farmacológico , Gastropatias/metabolismo , Succinatos/uso terapêutico , Vitamina U/uso terapêutico
3.
Naunyn Schmiedebergs Arch Pharmacol ; 391(2): 177-184, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29218374

RESUMO

The aim of this study is to investigate the therapeutic effects of vitamin U (Vit U) on lung tissue of pentyleneterazole (PTZ)-induced seizures in rats. Sprague Dawley male rats were randomly divided into four groups as follows: control (0.9% NaCl given, intraperitoneally); Vit U (50 mg/kg/day, for 7 days by gavage); PTZ; (60 mg/kg one dose, intraperitoneally); and PTZ + Vit U (in same dose and time). At the end of the experiment, lung tissues were taken and examined biochemically and cytologically. Lipid peroxidation (LPO), glutathione (GSH), sialic acid (SA), and nitric oxide (NO) levels, and superoxide dismutase (SOD) and catalase (CAT) activities were determined in lung homogenates. Imprinted lung samples were stained with May Grunwald-Giemsa stain and microscopically examined for the presence of collagen fibers, macrophage, leucocyte, and epithelial cells. PTZ administration significantly increased GSH level and CAT activity and significantly decreased SOD activity compared to the control group. Vit U administration significantly increased GSH level and CAT activity compared to the control group. GSH and NO levels significantly decreased in PTZ + Vit U group compared to the PTZ group. In cytologic analysis, increased collagen fibers, macrophages, leucocytes, and epithelial cells were observed in PTZ group compared to the control group, and Vit U administration decreased these cytological parameters compared to the PTZ group. The findings of this study support the possible protective role of using Vit U as an add-on therapy in order to prevent lung tissue injury which may occur during seizures in epilepsy.


Assuntos
Pulmão/metabolismo , Pentilenotetrazol/toxicidade , Convulsões/tratamento farmacológico , Convulsões/metabolismo , Vitamina U/uso terapêutico , Animais , Peroxidação de Lipídeos/efeitos dos fármacos , Peroxidação de Lipídeos/fisiologia , Pulmão/efeitos dos fármacos , Masculino , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/fisiologia , Ratos , Ratos Sprague-Dawley , Convulsões/induzido quimicamente , Resultado do Tratamento , Vitamina U/farmacologia
4.
Aust Vet J ; 85(9): 362-7, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17760939

RESUMO

OBJECTIVE: To assess the value of s-methylmethionine sulphonium chloride (SMMSC) (200 mg/kg) on nutritional performance of pigs and as prevention or therapy for oesophagogastric ulcers. DESIGN: Sixty pigs from a high health status herd with continuing oesophagogastric ulcer problems were endoscopically assessed for the presence or absence of oesophagogastric ulcers. Forty-eight pigs were then selected and allocated according to an initial oesophagogastric epithelial (ulcer score) classification to replicated treatment groups in a 2 x 2 factorial design. Weight gain and feed intake were measured over 49 d, after which pigs were killed and stomachs were collected, re-examined and scored for oesophagogastric ulceration. RESULTS: There was no difference over the 49 d in weight gain, feed intake and backfat in pigs with and without SMMSC supplementation between pigs with or without fully developed oesophagogastric ulcers at the start of the study. In pigs with an initially low ulcer score, feeding SMMSC did not prevent further oesophagogastric ulcer development. No significant effect of SMMSC was apparent when final mean oesophagogastric ulcer scores were compared in pigs with existing high ulcer score. However, further analysis of the changes in individual pig oesophagogastric ulcer scores during the experiment showed that the observed reductions in scores of the high ulcer group was significantly different from all other groups. CONCLUSION: This study has indicated that supplementation of pig diets with SMMSC cannot be justified unless the slight ulcer score improvement observed could be translated to some commercial production advantage such as a reduction in pig mortalities due to oesophagogastric ulcers. This study has further confirmed the benefit of endoscopy as a tool to enable objective assessment of oesophageal gastric health.


Assuntos
Antiulcerosos/uso terapêutico , Doenças do Esôfago/veterinária , Úlcera Gástrica/veterinária , Compostos de Sulfônio/uso terapêutico , Doenças dos Suínos/tratamento farmacológico , Vitamina U/uso terapêutico , Ração Animal , Animais , Doenças do Esôfago/tratamento farmacológico , Doenças do Esôfago/patologia , Doenças do Esôfago/prevenção & controle , Índice de Gravidade de Doença , Úlcera Gástrica/tratamento farmacológico , Úlcera Gástrica/patologia , Úlcera Gástrica/prevenção & controle , Suínos , Doenças dos Suínos/patologia , Doenças dos Suínos/prevenção & controle , Resultado do Tratamento , Aumento de Peso
5.
Eksp Klin Farmakol ; 69(2): 37-9, 2006.
Artigo em Russo | MEDLINE | ID: mdl-16845938

RESUMO

Gastrobiol--a new preparation comprising a mixture of lyophilized sea-buckthorn oil, vitamin U, and magnesium oxide, produces a pronounced antiulcerous action on the mucous membrane of the stomach and duodenum. The regenerative effect of gastrobiol is more pronounced than that of pure sea-buckthorn oil and methyluracil.


Assuntos
Antiulcerosos/uso terapêutico , Úlcera Duodenal/tratamento farmacológico , Hippophae/química , Óxido de Magnésio/uso terapêutico , Óleos de Plantas/uso terapêutico , Úlcera Gástrica/tratamento farmacológico , Vitamina U/uso terapêutico , Animais , Combinação de Medicamentos , Úlcera Duodenal/induzido quimicamente , Ratos , Ratos Endogâmicos , Úlcera Gástrica/induzido quimicamente
6.
Hum Exp Toxicol ; 34(9): 904-10, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25504687

RESUMO

Valproic acid (2-propyl-pentanoic acid, VPA) is the most widely prescribed antiepileptic drug due to its ability to treat a broad spectrum of seizure types. VPA exhibits various side effects such as organ toxicity, teratogenicity, and visual disturbances. S-Methylmethioninesulfonium is a derivative of the amino acid methionine and it is widely referred to as vitamin U (Vit U). This study was aimed to investigate the effects of Vit U on lens damage parameters of rats exposed to VPA. Female Sprague Dawley rats were divided into four groups. Group I comprised control animals. Group II included control rats supplemented with Vit U (50 mg/kg/day) for 15 days. Group III was given only VPA (500 mg/kg/day) for 15 days. Group IV was given VPA + Vit U (in same dose and time). Vit U was given to rats by gavage and VPA was given intraperitoneally. On the 16th day of experiment, all the animals which were fasted overnight were killed. Lens was taken from animals, homogenized in 0.9% saline to make up to 10% (w/v) homogenate. The homogenates were used for protein, glutathione, lipid peroxidation levels, and antioxidant enzymes activities. Lens lipid peroxidation levels and aldose reductase and sorbitol dehydrogenase activities were increased in VPA group. On the other hand, glutathione levels, superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, and paraoxonase activities were decreased in VPA groups. Treatment with Vit U reversed these effects. This study showed that Vit U exerted antioxidant properties and may prevent lens damage caused by VPA.


Assuntos
Anticonvulsivantes/toxicidade , Sequestradores de Radicais Livres/uso terapêutico , Doenças do Cristalino/induzido quimicamente , Doenças do Cristalino/prevenção & controle , Ácido Valproico/toxicidade , Vitamina U/uso terapêutico , Vitaminas/uso terapêutico , Animais , Antioxidantes/metabolismo , Feminino , Cristalino/patologia , Peroxidação de Lipídeos/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley
7.
J Pharm Sci ; 81(7): 698-700, 1992 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1403707

RESUMO

Reserpine (intraperitoneal, 5 mg/kg every day for 5 days) produced chronic ulceration of the rat stomach 2 weeks postdose. Gavage with 1% DL-cysteine or DL-methionine-S-methylsulfonium chloride at 1 mL/day for 2 weeks and 5 days protected against ulceration in 30% of the rats, and this protection extended to 80% of cases with 2% solutions. Similar gavage with 5% solutions protected all rats against ulceration without significantly influencing the basal H+ output [13.1 +/- 0.3 and 14.2 +/- 0.2 mumol for DL-cysteine and DL-methionine-S-methylsulfonium chloride, respectively, versus 15.1 +/- 0.4 mumol (mean +/- standard error of the mean; n = 10)]; that is, cytoprotection was achieved.


Assuntos
Cisteína/uso terapêutico , Úlcera Gástrica/prevenção & controle , Vitamina U/uso terapêutico , Animais , Cisteína/administração & dosagem , Feminino , Masculino , Ratos , Ratos Endogâmicos , Reserpina , Úlcera Gástrica/induzido quimicamente , Vitamina U/administração & dosagem
8.
J Pharm Sci ; 81(1): 70-3, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1619573

RESUMO

One milliliter of 1, 2, or 5% DL-cysteine (cysteine) or DL-methionine methylsulfonium chloride (MMSC) was instilled into the rat stomach 1, 24, and 48 h after giving ethanol (1 mL of 40% solution) by gavage. One hour following the administration of ethanol, gastric mucosal injury was seen in all the animals (22.6 +/- 1.1 mm2, mean +/- SEM; n = 10). Twenty-four hours after giving the ethanol, all the rats treated with cysteine or MMSC still had the mucosal injury. Treatment with 2% cysteine or MMSC significantly (p less than 0.01) reduced the extent of this injury (10.2 +/- 0.6 and 10.1 +/- 0.5 mm2, respectively, versus 20.7 +/- 1.2 mm2, mean +/- SEM; n = 10), an action that was similarly achieved by the 5% solutions (10.1 +/- 0.5 and 9.9 +/- 0.3 mm2, respectively, versus 20.7 +/- 1.2 mm2, mean +/- SEM; n = 10). Forty-eight hours following the administration of ethanol, 30% of the animals given 1% cysteine or MMSC still had gastric mucosal injury, which was significantly (p less than 0.001) less extensive than that seen with ethanol alone (3.8 +/- 0.3 and 4.1 +/- 0.3 mm2, respectively, versus 13.1 +/- 0.8 mm2, mean +/- SEM; n = 10). At this time period, however, none of the animals treated with 2 or 5% solutions of cysteine or MMSC still had any injury. Healing of the ethanol-induced injury was confirmed microscopically and was achieved by regeneration.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Cisteína/farmacologia , Mucosa Gástrica/efeitos dos fármacos , Gastrite/tratamento farmacológico , Úlcera Gástrica/tratamento farmacológico , Vitamina U/farmacologia , Animais , Cisteína/administração & dosagem , Cisteína/uso terapêutico , Relação Dose-Resposta a Droga , Etanol/toxicidade , Feminino , Mucosa Gástrica/patologia , Gastrite/patologia , Masculino , Ratos , Ratos Endogâmicos , Reserpina , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/patologia , Vitamina U/administração & dosagem , Vitamina U/uso terapêutico
9.
Vet Rec ; 137(12): 290-3, 1995 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-8533223

RESUMO

Four groups of about 86 pigs from a common source were fed a grower diet from 25 kg to 45 kg liveweight, and then from 45 to 107 kg liveweight they were offered one of four diets ad libitum: A) normal commercial feed, ground through a 3 mm screen (the control diet), B) the same diet ground through a 6 mm screen, C) the control diet to which lucerne meal was added before the diet was ground to increase its crude fibre content, and D) the control diet to which was added 400 ppm S-methylmethionine-sulphonium chloride (MMSC). All the diets were pelleted. Approximately 21 per cent of the animals fed the control diet had severe oesophagogastric erosions and/or ulcers after slaughter. The addition of 400 ppm MMSC decreased (P = 0.066) the proportion of severe oesophagogastric erosions and/or ulcers by about 50 per cent compared with the control diet. The diet with the higher crude fibre content (but finely ground) did not have a significant effect on the proportion of severe oesophagogastric erosions and/or ulcers. There was a tendency for the pigs fed the diet ground through a 6 mm screen instead of a 3 mm screen, to have fewer severe oesophagogastric erosions and/or ulcers. However, there were only small differences between the particle size distribution obtained from the wet sieve analysis of the two diets. As a result, the observed tendency for a decrease in the proportion of severe oesophagogastric erosions and/or ulcers in pigs fed the diet milled through the larger screen size was of questionable significance.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Ração Animal , Fibras na Dieta , Doenças do Esôfago/veterinária , Úlcera Gástrica/veterinária , Doenças dos Suínos/tratamento farmacológico , Suínos/crescimento & desenvolvimento , Vitamina U/uso terapêutico , Animais , Doenças do Esôfago/tratamento farmacológico , Úlcera Gástrica/tratamento farmacológico , Úlcera/tratamento farmacológico , Úlcera/veterinária
10.
Artigo em Russo | MEDLINE | ID: mdl-7315057

RESUMO

Results of treating depressive states (manic-depressive psychosis, involutional and vascular depressions) with S-methylmethionine (vitamin "U") are presented. The vitamin was found to produce a marked antidepressant effect in depressive states of various nosology irrespectively of the duration of the depression phase or preceding treatment. The authors suggest that studies of the effect of the vitamin and its clinical use as an antidepressant should be continued.


Assuntos
Antidepressivos , Transtorno Depressivo/tratamento farmacológico , Transtornos Neurocognitivos/tratamento farmacológico , Vitamina U/uso terapêutico , Vitaminas/uso terapêutico , Adulto , Idoso , Antidepressivos/efeitos adversos , Transtorno Bipolar/tratamento farmacológico , Transtornos Cerebrovasculares/complicações , Feminino , Humanos , Pessoa de Meia-Idade , Síndrome , Vitamina U/efeitos adversos
11.
Eksp Klin Farmakol ; 61(5): 21-3, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9854627

RESUMO

In experimental study of antiulcerative activity of dibunol on various models of gastric ulcers in rats the drug caused a marked antiulcerative effect in all of them, reduced the incidence of ulcer formation, and shortened the time of ulcer healing. In a model of "acetic" ulcer dibunol oil solution led to quick normalization of lipid peroxidation in the gastric mucosa, which was evidence of high antioxidant activity in cases of ulcer lesions.


Assuntos
Antiulcerosos/uso terapêutico , Antioxidantes/uso terapêutico , Hidroxitolueno Butilado/uso terapêutico , Animais , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Ratos , Úlcera Gástrica/tratamento farmacológico , Úlcera Gástrica/etiologia , Úlcera Gástrica/metabolismo , Fatores de Tempo , Vitamina E/uso terapêutico , Vitamina U/uso terapêutico
12.
Vopr Onkol ; 31(4): 46-53, 1985.
Artigo em Russo | MEDLINE | ID: mdl-4002669

RESUMO

The study was concerned with the functional condition of the sympatho-adrenal system in 80 patients with cancer of the esophagus and proximal part of the stomach who had undergone surgery and received combined treatment, coupled with measures aimed at correcting the sympatho-adrenal system in some cases. Treatment with phenformin, decaris and S-methylmethionine was shown to produce a favorable effect on certain stages of catecholamine synthesis and metabolism as well as on immunologic indexes and hemodynamic stability.


Assuntos
Medula Suprarrenal/fisiopatologia , Neoplasias Esofágicas/fisiopatologia , Neoplasias Gástricas/fisiopatologia , Sistema Nervoso Simpático/fisiopatologia , Medula Suprarrenal/efeitos dos fármacos , Adulto , Idoso , Catecolaminas/metabolismo , Terapia Combinada , Epinefrina , Neoplasias Esofágicas/imunologia , Neoplasias Esofágicas/cirurgia , Neoplasias Esofágicas/terapia , Esôfago/cirurgia , Feminino , Gastrectomia , Humanos , Imunoglobulina M/análise , Levamisol/uso terapêutico , Masculino , Pessoa de Meia-Idade , Fenformin/uso terapêutico , Formação de Roseta , Neoplasias Gástricas/imunologia , Neoplasias Gástricas/cirurgia , Neoplasias Gástricas/terapia , Sistema Nervoso Simpático/efeitos dos fármacos , Vitamina U/uso terapêutico
13.
Food Chem Toxicol ; 50(10): 3562-6, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22889891

RESUMO

In this study, we aimed to investigate the effects of vitamin U (Vit U) on valproic acid (VPA)-induced liver damage. Female Sprague Dawley rats were randomly divided into four groups. Group I was intact control animals. Group II was control rats given Vit U (50 mg/kg/day) for fifteen days. Group III was given only VPA (500 mg/kg/day) for fifteen days. Group IV was given VPA+Vit U (in same dose and time). Vit U was given to rats by gavage and VPA was given intraperitoneally. On the 16th day of experiment, all the animals were fasted overnight and then sacrificed under ether anesthesia. Liver tissue was taken from animals, homogenized in 0.9% saline to make up to 10% homogenate. Liver aspartate and alanine transaminases, alkaline phosphatase, lactate dehydrogenase, myeloperoxidase, sorbitol dehydrogenase, glutamate dehydrogenase and xanthine oxidase activities and lipid peroxidation levels were increased and paraoxonase activity and glutathione levels were decreased in VPA group. Treatment with Vit U reversed these effects. These results demonstrated that administration of Vit U is a potentially beneficial agent to reduce the liver damage in VPA induced hepatotoxicity, probably by decreasing oxidative stress.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Ácido Valproico/toxicidade , Vitamina U/uso terapêutico , Animais , Feminino , Fígado/efeitos dos fármacos , Fígado/enzimologia , Fígado/metabolismo , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley
14.
Metallomics ; 3(7): 683-5, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21701765

RESUMO

The insulinomimetic activity of a Zn(ii) complex is reported. The effects of the Zn(ii) complex with ascorbic acid (Vitamin C; VC), methylmethionine sulfonium chloride (Vitamin U; VU) and l-carnitine were assessed in diet-induced metabolic syndrome model rats. Zn(VU)(2)Cl(2) and Zn(VC)Cl(2) were suggested to be useful supplementary materials for preventing metabolic syndrome by reducing visceral adipose tissues or accelerating blood fluidity.


Assuntos
Ácido Ascórbico/uso terapêutico , Carnitina/uso terapêutico , Síndrome Metabólica/tratamento farmacológico , Vitamina U/uso terapêutico , Zinco/uso terapêutico , Adipócitos/efeitos dos fármacos , Adipócitos/metabolismo , Tecido Adiposo/efeitos dos fármacos , Tecido Adiposo/metabolismo , Tecido Adiposo/patologia , Animais , Ácido Ascórbico/farmacologia , Peso Corporal/efeitos dos fármacos , Carnitina/farmacologia , Separação Celular , Dieta , Modelos Animais de Doenças , Ácidos Graxos/metabolismo , Comportamento Alimentar/efeitos dos fármacos , Glucose/farmacologia , Concentração Inibidora 50 , Insulina/análogos & derivados , Síndrome Metabólica/prevenção & controle , Ratos , Vitamina U/farmacologia , Zinco/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA